Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Hillary Campbell

Nurse Practitioner Tucson, AZ Nurse Practitioner

NPI 1790427334 CMS profile 11383109

6567 E Carondelet Dr Ste 305, Tucson, AZ 85710

Open in the dashboard

General payments

$16,142

634 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hillary Campbell of Tucson, AZ is reported in the CMS Open Payments database as having received $16,142 across 634 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,525 122
2024 General $5,266 177
2023 General $5,097 226
2022 General $2,254 109

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hillary Campbell
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Hillary Campbell were reported at $3,525. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Hillary Campbell Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $2,254 $152 $48–$470 $149
2023 $5,097 $166 $54–$529 $160
2024 $5,266 $173 $55–$556 $164
2025 $3,525 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Stryker Corporation $10,929 468 payments
  2. DePuy Synthes Sales Inc. $2,638 115 payments
  3. Qapel Medical Inc $1,517 2 payments
  4. Rapid Medical LTD $484 23 payments
  5. Medtronic, Inc. $367 18 payments
  6. Cordis US Corp. $92 4 payments
  7. Imperative Care, INc $72 2 payments
  8. MicroVention, Inc. $25 1 payment
  9. MIMEDX Group, Inc. $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $16,142 634 payments
Products named General payments · program years 2022–2025
  1. SURPASS EVOLVE $5,354 221 payments
  2. TARGET $4,140 185 payments
  3. AXS VECTA 71 $2,175 97 payments
  4. TREVO $1,377 62 payments
  5. CEREPAK UNIFORM $865 33 payments
  6. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $484 23 payments
  7. COMANECI 17 $484 23 payments
  8. TRUFILL $454 24 payments
  9. EMBOGUARD $363 15 payments
  10. N/A $316 13 payments
  11. Other $1,845 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

163

Median for Nurse Practitioner: 389

Drug cost

$58,035

Median for Nurse Practitioner: $21,885

Branded share of claims

62%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 101 $56,379
Prasugrel Hcl Generic 62 $1,656

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$22,638

Medicare's payments for the services billed

Medicare patients

148

Average age 77

Services billed

362

90 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Ischemic heart disease 45%
Atrial fibrillation 43%
Chronic kidney disease 36%
Depression 36%
Diabetes 32%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

634 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record